ClassID:

115931

C12Y207/07001 - CPC Classification

Classification description:

Transferases transferring phosphorus-containing groups (2.7); Nucleotidyltransferases (2.7.7) Nicotinamide-nucleotide adenylyltransferase (2.7.7.1)

Recent Application in this class:
#1
20250381177
2025-12-18

TREATMENT AND PREVENTION OF OCULAR NEURODEGENERATIVE DISORDER

#2
20250269068
2025-08-28

Gene Therapy for NMNAT1-Associated Retinal Degeneration

#3
20250019708
2025-01-16

METHODS FOR THE TREATMENT OF HRD CANCER AND BRCA-ASSOCIATED CANCER

#4
20240293581
2024-09-05

NEUROPROTECTION GENE THERAPY

#5
20220354838
2022-11-10

TREATMENT AND PREVENTION OF OCULAR NEURODEGENERATIVE DISORDER

#6
20210371843
2021-12-02

Genetically engineered bacteria, its construction method and its application in producing NAD method

#7
20210309691
2021-10-07

METHODS AND COMPOSITIONS FOR NUCLEOSIDE TRIPHOSPHATE AND RIBONUCLEIC ACID PRODUCTION

#8
20210299277
2021-09-30

Gene therapy for NMNAT1-associated retinal degeneration

#9
20200405736
2020-12-31

Targeting NAD+ to treat chemotherapy and radiotherapy induced cognitive impairment, neuropathies and inactivity

#10
20190144489
2019-05-16

Methods and compositions for nucleoside triphosphate and ribonucleic acid production

#11
20190078065
2019-03-14

MODIFIED DNA POLYMERASES

#12
20190071680
2019-03-07

MICROBIAL PRODUCTION OF NICOTINIC ACID RIBOSIDE

#13
20180344719
2018-12-06

Treatment and prevention of ocular neurodegenerative disorder

#14
20180338991
2018-11-29

NAD BIOSYNTHESIS AND PRECURSORS FOR THE TREATMENT AND PREVENTION OF CANCER AND PROLIFERATION

#15
20180125871
2018-05-10

Targeting NAD to treat chemotherapy and radiotherapy induced cognitive impairment, neuropathies and inactivity

#16
20150313930
2015-11-05

NAD biosynthesis and precursors for the treatment and prevention of cancer and proliferation

#17
20150265642
2015-09-24

NAD BIOSYNTHESIS AND PRECURSORS IN THE PREVENTION AND TREATMENT OF INFLAMMATION